Meridian Bioscience

Meridian Bioscience Net Income

The Net Income of Meridian Bioscience (VIVO) as of Oct 26, 2026 is 42.46 M USD. In the previous year, Net Income was 71.41 M USD — a change of -40.54% (lower).

Net Income

42.46 MUSD

YoY

-40.54%

Last updated:

In 2022, Meridian Bioscience's profit amounted to 42.46 M USD, a -40.54% increase from the 71.41 M USD profit recorded in the previous year.

The Meridian Bioscience Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Income
Date
Net Income
Jan 1, 2018
23.80 M USD
Jan 1, 2019
24.40 M USD
Jan 1, 2020
46.20 M USD
Jan 1, 2021
71.41 M USD
Jan 1, 2022
42.46 M USD
Jan 1, 2023 (e)
37.34 M USD
Jan 1, 2024 (e)
26.22 M USD
Jan 1, 2025 (e)
18.78 M USD
The Meridian Bioscience Net Income history
YEARNet IncomeYoY
est18.78 MUSD-28.38%
est26.22 MUSD-29.79%
est37.34 MUSD-12.05%
42.46 MUSD-40.54%
71.41 MUSD+54.56%
46.20 MUSD+89.34%
24.40 MUSD+2.52%
23.80 MUSD+10.19%
21.60 MUSD-32.92%
32.20 MUSD-9.30%
35.50 MUSD+2.31%
34.70 MUSD-8.68%
38.00 MUSD+13.77%
33.40 MUSD+24.63%
26.80 MUSD+0.75%
26.60 MUSD-18.90%
32.80 MUSD+8.61%
30.20 MUSD+13.11%
26.70 MUSD+45.90%
18.30 MUSD+45.24%
12.60 MUSD+36.96%
9.20 MUSD+31.43%
7.00 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Meridian Bioscience Revenue

Meridian Bioscience Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
213.60 M USD
44.70 M USD
23.80 M USD
Jan 1, 2019
201.00 M USD
38.90 M USD
24.40 M USD
Jan 1, 2020
253.70 M USD
68.00 M USD
46.20 M USD
Jan 1, 2021
317.90 M USD
101.83 M USD
71.41 M USD
Jan 1, 2022
333.02 M USD
75.60 M USD
42.46 M USD
Jan 1, 2023 (e)
294.11 M USD
46.97 M USD
37.34 M USD
Jan 1, 2024 (e)
302.36 M USD
32.45 M USD
26.22 M USD
Jan 1, 2025 (e)
300.53 M USD
22.86 M USD
18.78 M USD

Meridian Bioscience Margins

Meridian Bioscience stock margins

The Meridian Bioscience margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Meridian Bioscience. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Meridian Bioscience.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
61.33 %
20.93 %
11.14 %
Jan 1, 2019
59.05 %
19.35 %
12.14 %
Jan 1, 2020
61.57 %
26.80 %
18.21 %
Jan 1, 2021
63.27 %
32.03 %
22.46 %
Jan 1, 2022
56.56 %
22.70 %
12.75 %
Jan 1, 2023 (e)
56.56 %
15.97 %
12.70 %
Jan 1, 2024 (e)
56.56 %
10.73 %
8.67 %
Jan 1, 2025 (e)
56.56 %
7.61 %
6.25 %

Meridian Bioscience Stock analysis

What does Meridian Bioscience do? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.

Net Income Details

Understanding Meridian Bioscience's Profit Margins

The profit margins of Meridian Bioscience represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Meridian Bioscience's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Meridian Bioscience's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Meridian Bioscience's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Meridian Bioscience’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Meridian Bioscience stock

Net Income of Meridian Bioscience is 42.46 M USD in 2022.

Net Income of Meridian Bioscience changed from 71.41 M USD to 42.46 M USD, representing a -40.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Income Meridian Bioscience since 2006 – with annual values, charts, and detailed analysis.

The achievement of a profit is the biggest goal of a company. The profit can be used for distribution or reinvestment. The profit (also called annual surplus or EAT, earnings after taxes) is the positive difference between income and expenses in a period as shown in the income statement. A negative annual surplus is called annual loss. Both performance measures are also combined under the neutral term annual result.

The Net Income is derived from all revenues / sales minus the expenses in the period under review. The following overview clearly shows which positions contribute to the annual surplus and where the differences lie compared to other variants of profit such as EBT, EBIT, and EBITDA.

Net Income's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Income's Meridian Bioscience historically and in real time.

The profit in evaluating a stock

History, usage, calculation, and application of earnings in securities trading.

The history of earnings dates back to the beginnings of modern business organization. Since the beginning of industrialization, companies have been established to generate profits, and profits have been considered an essential part of corporate management. In recent years, the importance of earnings for investors has continued to rise, as many investors seek to find stocks that generate solid earnings.

Use of Profits

In securities trading, profits are used to determine the value of a stock. A company that generates profits is considered financially healthy and its stocks are valued higher, while a company that does not generate profits is considered less reliable and therefore receives a lower valuation. Investors can review the profits of each company by examining the relevant documents such as the income statement, the annual financial statements, and the income tax audits.

Calculation of profits

There are several different ways to calculate profits. The simplest way to calculate profits is by calculating net earnings. Net earnings are calculated by subtracting the company's expenses from its revenue. Another way to calculate profits is by calculating operating income. Operating income is calculated by subtracting the company's materials costs and employee wages and salaries from its revenue.

Use of profits

There are many different ways in which investors can use profits when evaluating stocks. One example is calculating the price-to-earnings ratio (P/E ratio). The P/E ratio is the relationship between the price of a stock and the company's earnings. When calculating the P/E ratio, the stock price is divided by the company's earnings. A low P/E value indicates that the stock has a good price-performance ratio, and a high P/E value indicates that the stock has a poor price-performance ratio.

Advantages and disadvantages of using profits

There are many advantages to using earnings in securities trading. Firstly, investors can check the financial health of a company by analyzing earnings. Secondly, investors can make a better decision about the valuation of a stock by calculating the P/E ratio. Thirdly, investors can reduce their risk by choosing stocks with a low P/E ratio.

However, there are also some drawbacks to relying on profits. Firstly, profits can be distorted if a company increases its profits through cost-cutting measures. Secondly, profits can present an inaccurate picture of a company's financial health if they are not calculated correctly. Thirdly, profits may not always be a reliable indicator of a company's future, as they can easily fluctuate.

t('components_kpi_Explanation_34')

Overall, it can be said that profits in securities trading are an important indicator of a company's financial health. Investors can analyze profits to get a better understanding of the company's financial health and make informed decisions about stock valuation. However, there are some disadvantages to using profits as they can sometimes be distorted or inaccurate. Therefore, it is important for investors to be cautious and carefully analyze profits before making a decision to buy or sell stocks.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Meridian Bioscience

All Key Metrics — Meridian Bioscience